PatsFans.com Menu
PatsFans.com - The Hub For New England Patriots Fans

OT - Since Brady accepted suspension Exponet lost $247M (16%) from valuation


Status
Not open for further replies.
My impression is that the accuracy of the Exponent Report is not a hot topic outside of this message board. Probably not enough to move markets.
Lets ask Exponent about it at the quarterly earnings call. If the overwhelming academic and scientific communities' near universal criticism of their sham work on deflategate is hurting business.
 
Last edited:
they don't really have any direct competitors--mostly small specialist boutique firms. they work on 6000-7000 projects a year for roughly 2000 clients in the following fields:

Engineering & Other Scientific
Biomechanics, Biomedical Engineering, Buildings & Structures, Civil Engineering, Construction Consulting, Electrical Engineering & Computer Science, Engineering Management Consulting, Human Factors, Industrial Structures, Materials & Corrosion Engineering, Mechanical Engineering, Polymer Science & Materials Chemistry, Statistical & Data Sciences, Technology Development, Thermal Sciences, and Vehicle Analysis

Environmental & Health
Chemical Regulation & Food Safety, Ecological & Biological Sciences, Environmental & Earth Sciences, Epidemiology, Biostatistics & Computational Biology, Occupational & Environmental Health Risk Assessment, and Toxicology & Mechanistic Biology

no other firm can really compete with them in terms of diversity of fields that they cover, so they can actually charge a premium for their services.

So they don't work in the field of thermodynamics, or chemical engineering which is where the IGL comes from and is used (I assume thermal sciences is combustion related)? Interesting
 
@Dr Pain, @bbobbo, @Hammer of Thor, and others!

Interesting discussion. I learned something. Clearly Deflategate had nothing to do with the BP Contract termination and the diminished revenue streams related to the price of oil, which latter have impacted many businesses.

On the surface this is a very healthy company. It's trading at four times Book. It is very liquid (Cash on Hand exceeds total Current Liabilities). Total Debt(ST and LT)/Equity is 0.39. There is very little LTD at all. But, now the market is punishing it. Why?

Revenues historically have gone up three percent or so per year with flat expenses, so everything fell to the bottom line. Thus, the high multiple. They are very generous to themselves with their Stock Based Comp, but that's not unusual for Information-based Service Firms.

Now, however, their revenues have flattened and the expenses are ticking up, so EBITDA is down. Markets are cruel and they've been hammered.

So, my 25 cent analysis is that this is a company run by a bunch of scientists who are now in over their heads as businesspersons and is at a turning point.

The company has a high multiple because it has been a reliable producer of cash. It either has to grow earnings again or the Analysts will insist that it cut costs and scale back. Or, someone will come in and buy it and do the job for them. With all the Cash and Short Term Investments on the Balance Sheet, you could use their own Cash for a good part of the purchase price.

If I were advising them, I'd suggest that, if they can't grow revenues organically, they use some of that cash along with their high-multiple shares to buy a related company to enhance their earnings and put in a bunch of poison pills to make a takeover unattractive.

If I have nothing else to do next Wednesday at 4:30, I think I'll listen to the Earnings Call.


PS: All the high level, highly visible criticism of their work for the NFL has drawn unwanted media attention to more serious matters related to Second Hand Smoke and Toxic Waste. In other words, if I'm going to need an Expert Witness to sweet talk a jury into seeing things my way, I might think twice about the line of questioning that a ravenous Attorney on the other side might pursue against an Exponent employee on the Witness Stand. But, I don't think that alone is sufficient to explain what's going on.
 
Last edited:
The day Brady accepted the suspension, July 15 their stock was $58.90 it closed yesterday at $49.42, around a 16% drop decreasing their valuation from $1,537,000,000 to $1,290,000,000. A drop of $247 million dollars while during the same period the NASDAQ average has gone up 4.46%. If Exponent had simply average performance of any company on NASDAQ since Brady accepted the suspension, they would have increased value by $68M not gone down by $247M.

Did their reputation take a hit when Brady took the suspension and the narrative turned almost completely against the NFL and this has cost the shareholders? Exponent tried to counter with that weak NYT whine article which never addressed the massive academic and scientific community criticism of their deflategate work.

For any company like them, their value is based on reputation. It has been said many times, they are hired to give the client the answer they wanted but if a jury knows this is their reputation, then their work will be potentially damaging to their client using them. Exponent had a big stock increase after the NFL won in court at the end of April. Could Exponent economists make a compelling case for this linkage if hired to do so? I think that is more probable than not.

View attachment 14460

View attachment 14461

Stock call is tomorrow if Anyone wants to try and get a question in.

Date: Wednesday, October 19, 2016

Time: 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time

Live Call: (800) 768-6563 or (785) 830-7991
 
Status
Not open for further replies.


Bruschi’s Proudest Moment: Former LB Speaks to MusketFire’s Marshall in Recent Interview
Monday Patriots Notebook 4/22: News and Notes
Patriots News 4-21, Kraft-Belichick, A.J. Brown Trade?
MORSE: Patriots Draft Needs and Draft Related Info
Friday Patriots Notebook 4/19: News and Notes
TRANSCRIPT: Eliot Wolf’s Pre-Draft Press Conference 4/18/24
Thursday Patriots Notebook 4/18: News and Notes
Wednesday Patriots Notebook 4/17: News and Notes
Tuesday Patriots Notebook 4/16: News and Notes
Monday Patriots Notebook 4/15: News and Notes
Back
Top